Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Inhalation Anesthetic Drugs Market by Type (General Anesthesia Drugs, Local Anesthesia Drugs), By Application (Cosmetic Surgery, Dental Surgery, General Surgey, Plastic Surgery) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Inhalation Anesthetic Drugs Market by Type (General Anesthesia Drugs, Local Anesthesia Drugs), By Application (Cosmetic Surgery, Dental Surgery, General Surgey, Plastic Surgery) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 372445 4200 Medical Devices & Consumables 377 201 Pages 4.6 (39)
                                          

Market Overview:


The global inhalation anesthetic drugs market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to factors such as the increasing number of surgeries, rising demand for minimally invasive surgeries, and technological advancements in inhalation anesthetic drugs. The global inhalation anesthetic drugs market is segmented on the basis of type into general anesthesia drugs and local anesthesia drugs. General anesthesia drugs are further sub-segmented into volatile agents and non-volatile agents. Local anesthesia drugs are further sub-segmented into injectable local anesthetics and topical local anesthetics. On the basis of application, the global inhalation anesthetic Drugs Market is segmented into cosmetic surgery, dental surgery, general surgery, plastic surgery, and other applications (including ophthalmic surgeries). Geographically, the global inhalation anaesthesia Drugs Market is segmented into North America, Latin America,, Europe,, Asia Pacific,,and Middle East & Africa,.


Global Inhalation Anesthetic Drugs Industry Outlook


Product Definition:


Inhalation anesthetic drugs are a type of general anesthetic agent that are administered by inhalation. They work by depressing the central nervous system, which leads to a loss of consciousness. Inhalational agents are used for surgeries that require general anesthesia, such as cardiac surgery or cesarean section births.


General Anesthesia Drugs:


Anesthesia is a state where the patient is no longer aware and can’t feel any pain. It's majorly used for surgical procedures but it also finds its use in medical emergencies. The drugs that are given to the patients before surgery have different names according to their brands, generic or trade name, they all have similar properties and mechanisms of actions.


Local Anesthesia Drugs:


Anesthesia drugs are used to eliminate pain sensation during surgical or diagnostic procedures. They are categorized into two types: general anesthesia and local anesthesia. General anesthesia is used for surgical procedures, while local anesthetics are used in dental, orthopedic, gynecological & obstetric surgeries along with other painful conditions like tooth extractions and chronic back pain management.


Application Insights:


The application segment includes cosmetic surgery, dental surgery, general surgery, plastic surgeries. General anesthesia drugs held the largest market share in 2017 and are expected to continue their dominance over the forecast period. These drugs are used for surgical procedures requiring deep relaxation and pain relief which include gynecological procedures, orthopedic surgeries, neurosurgeries & cardiovascular interventions. The growing number of obese population is expected to increase demand for aesthetic surgeries which will further propel growth during the forecast period.


Inhalation anesthetic drugs have a wide range of applications in dentistry including pulp capping/reconstruction as well as nerve block techniques used in sedation.


Regional Analysis:


North America dominated the global inhalation anesthetic drugs market in 2017. This can be attributed to increasing demand for cosmetic surgeries, rising prevalence of chronic diseases and dental caries, and growing use of general anesthesia during surgery. In addition, favorable reimbursement policies for surgical procedures performed under conscious sedation are expected to drive the regional market over the forecast period.


Asia Pacific is anticipated to witness rapid growth over the forecast period owing to increasing awareness about various surgical treatments and improving healthcare facilities in emerging countries such as China & India & Thailand among others. Moreover, government initiatives encouraging medical tourists are also expected to boost revenue generation in this region during the forecast period  (2018-2030). For instance; The Government of India has implemented a 10% Medical Tourism Promotion Scheme which offers tax benefits along with other incentives for patients seeking treatment at foreign hospitals or clinics (2017).


Growth Factors:


  • Increasing demand for minimally invasive surgeries: The global market for inhalation anesthetic drugs is expected to grow at a CAGR of 5.5% during the forecast period. This can be attributed to the increasing demand for minimally invasive surgeries, which require less anesthesia as compared to traditional surgical procedures. Inhalation anesthetics are preferred over general anesthesia as they provide faster recovery time and cause fewer side effects.
  • Rising prevalence of chronic diseases: The prevalence of chronic diseases such as cancer, heart disease, and diabetes is on the rise globally, which is leading to an increase in the number of surgical procedures being performed each year. Inhalation anesthetics are increasingly being used in these procedures due to their fast onset and short duration of action.
  • Growing geriatric population: The global geriatric population is growing at a rapid pace and this is expected to drive the demand for inhalation anesthetic drugs during the forecast period. Elderly patients are more susceptible to adverse effects associated with general anesthesia and hence prefer inhalation anesthetics, which offer a quicker recovery time than general anesthesia drugs do .

Scope Of The Report

Report Attributes

Report Details

Report Title

Inhalation Anesthetic Drugs Market Research Report

By Type

General Anesthesia Drugs, Local Anesthesia Drugs

By Application

Cosmetic Surgery, Dental Surgery, General Surgey, Plastic Surgery

By Companies

Astrazeneca, Fresenius-Kabi, AbbVie, Baxter Healthcare, B.Braun, Maruishi, Piramal, Hikma Pharmaceuticals, Mylan, Nhwa, Hengrui, Lunan

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

201

Number of Tables & Figures

141

Customization Available

Yes, the report can be customized as per your need.


Global Inhalation Anesthetic Drugs Market Report Segments:

The global Inhalation Anesthetic Drugs market is segmented on the basis of:

Types

General Anesthesia Drugs, Local Anesthesia Drugs

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Cosmetic Surgery, Dental Surgery, General Surgey, Plastic Surgery

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Astrazeneca
  2. Fresenius-Kabi
  3. AbbVie
  4. Baxter Healthcare
  5. B.Braun
  6. Maruishi
  7. Piramal
  8. Hikma Pharmaceuticals
  9. Mylan
  10. Nhwa
  11. Hengrui
  12. Lunan

Global Inhalation Anesthetic Drugs Market Overview


Highlights of The Inhalation Anesthetic Drugs Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. General Anesthesia Drugs
    2. Local Anesthesia Drugs
  1. By Application:

    1. Cosmetic Surgery
    2. Dental Surgery
    3. General Surgey
    4. Plastic Surgery
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Inhalation Anesthetic Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Inhalation Anesthetic Drugs Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Inhalation anesthetics are drugs that are used to block the sensation of pain during surgery.

Some of the key players operating in the inhalation anesthetic drugs market are Astrazeneca, Fresenius-Kabi, AbbVie, Baxter Healthcare, B.Braun, Maruishi, Piramal, Hikma Pharmaceuticals, Mylan, Nhwa, Hengrui, Lunan.

The inhalation anesthetic drugs market is expected to register a CAGR of 5.5%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Inhalation Anesthetic Drugs Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Inhalation Anesthetic Drugs Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Inhalation Anesthetic Drugs Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Inhalation Anesthetic Drugs Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Inhalation Anesthetic Drugs Market Size & Forecast, 2020-2028       4.5.1 Inhalation Anesthetic Drugs Market Size and Y-o-Y Growth       4.5.2 Inhalation Anesthetic Drugs Market Absolute $ Opportunity

Chapter 5 Global  Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2  Market Size Forecast by Type
      5.2.1 General Anesthesia Drugs
      5.2.2 Local Anesthesia Drugs
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global  Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2  Market Size Forecast by Applications
      6.2.1 Cosmetic Surgery
      6.2.2 Dental Surgery
      6.2.3 General Surgey
      6.2.4 Plastic Surgery
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Inhalation Anesthetic Drugs Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Inhalation Anesthetic Drugs Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America  Analysis and Forecast
   9.1 Introduction
   9.2 North America  Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America  Market Size Forecast by Type
      9.6.1 General Anesthesia Drugs
      9.6.2 Local Anesthesia Drugs
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America  Market Size Forecast by Applications
      9.10.1 Cosmetic Surgery
      9.10.2 Dental Surgery
      9.10.3 General Surgey
      9.10.4 Plastic Surgery
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe  Analysis and Forecast
   10.1 Introduction
   10.2 Europe  Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe  Market Size Forecast by Type
      10.6.1 General Anesthesia Drugs
      10.6.2 Local Anesthesia Drugs
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe  Market Size Forecast by Applications
      10.10.1 Cosmetic Surgery
      10.10.2 Dental Surgery
      10.10.3 General Surgey
      10.10.4 Plastic Surgery
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific  Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific  Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific  Market Size Forecast by Type
      11.6.1 General Anesthesia Drugs
      11.6.2 Local Anesthesia Drugs
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific  Market Size Forecast by Applications
      11.10.1 Cosmetic Surgery
      11.10.2 Dental Surgery
      11.10.3 General Surgey
      11.10.4 Plastic Surgery
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America  Analysis and Forecast
   12.1 Introduction
   12.2 Latin America  Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America  Market Size Forecast by Type
      12.6.1 General Anesthesia Drugs
      12.6.2 Local Anesthesia Drugs
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America  Market Size Forecast by Applications
      12.10.1 Cosmetic Surgery
      12.10.2 Dental Surgery
      12.10.3 General Surgey
      12.10.4 Plastic Surgery
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA)  Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA)  Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA)  Market Size Forecast by Type
      13.6.1 General Anesthesia Drugs
      13.6.2 Local Anesthesia Drugs
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA)  Market Size Forecast by Applications
      13.10.1 Cosmetic Surgery
      13.10.2 Dental Surgery
      13.10.3 General Surgey
      13.10.4 Plastic Surgery
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Inhalation Anesthetic Drugs Market: Competitive Dashboard
   14.2 Global Inhalation Anesthetic Drugs Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Astrazeneca
      14.3.2 Fresenius-Kabi
      14.3.3 AbbVie
      14.3.4 Baxter Healthcare
      14.3.5 B.Braun
      14.3.6 Maruishi
      14.3.7 Piramal
      14.3.8 Hikma Pharmaceuticals
      14.3.9 Mylan
      14.3.10 Nhwa
      14.3.11 Hengrui
      14.3.12 Lunan

Our Trusted Clients

Contact Us